Skip to main contentSkip to search and navigation

UEF eREPOSITORY

    • English
    • suomi
  • English 
    • English
    • suomi
  • Login
View Item 
  •   Home
  • Artikkelit
  • Terveystieteiden tiedekunta
  • View Item
  •   Home
  • Artikkelit
  • Terveystieteiden tiedekunta
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Role of osteopontin and its regulation in pancreatic islet

Thumbnail
Files
Article (1.204Mb)
Self archived version
final draft
Date
2018
Author(s)
Cai M
Bompada P
Salehi A
Acosta JR
Prasad RB
Atac D
Laakso M
Groop L
De Marinis Y
Unique identifier
10.1016/j.bbrc.2017.11.147
Metadata
Show full item record
More information
Research Database SoleCris

Self-archived article

Citation
Cai M. Bompada P. Salehi A. Acosta JR. Prasad RB. Atac D. Laakso M. Groop L. De Marinis Y. (2018). Role of osteopontin and its regulation in pancreatic islet.  BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 495 (1) , 1426-1431. 10.1016/j.bbrc.2017.11.147.
Rights
© Elsevier Inc
Licensed under
CC BY-NC-ND https://creativecommons.org/licenses/by-nc-nd/4.0/
Abstract

Osteopontin (OPN) is involved in various physiological processes and also implicated in multiple pathological states. It has been suggested that OPN may have a role in type 2 diabetes (T2D) by protecting pancreatic islets and interaction with incretins. However, the regulation and function of OPN in islets, especially in humans, remains largely unexplored. In this study, we performed our investigations on both diabetic mouse model SUR1-E1506K+/+ and islets from human donors. We demonstrated that OPN protein, secretion and gene expression was elevated in the diabetic SUR1-E1506K+/+ islets. We also showed that high glucose and incretins simultaneously stimulated islet OPN secretion. In islets from human cadaver donors, OPN gene expression was elevated in diabetic islets, and externally added OPN significantly increased glucose-stimulated insulin secretion (GSIS) from diabetic but not normal glycemic donors. The increase in GSIS by OPN in diabetic human islets was Ca2+ dependent, which was abolished by Ca2+-channel inhibitor isradipine. Furthermore, we also confirmed that OPN promoted cell metabolic activity when challenged by high glucose. These observations provided evidence on the protective role of OPN in pancreatic islets under diabetic condition, and may point to novel therapeutic targets for islet protection in T2D.

Subjects
osteopontin   diabetes   hyperglycemia   islets   insulin   incretins   
URI
https://erepo.uef.fi/handle/123456789/6232
Link to the original item
http://dx.doi.org/10.1016/j.bbrc.2017.11.147
Publisher
Elsevier BV
Collections
  • Terveystieteiden tiedekunta [1324]
University of Eastern Finland
OpenAccess
eRepo
erepo@uef.fi
OpenUEF
Service provided by
the University of Eastern Finland Library
Library web pages
Twitter
Facebook
Youtube
Library blog
 sitemap
Search

Browse

All of the ArchiveResource types & CollectionsBy Issue DateAuthorsTitlesSubjectsFacultyDepartmentFull organizationSeriesMain subjectThis CollectionBy Issue DateAuthorsTitlesSubjectsFacultyDepartmentFull organizationSeriesMain subject

My Account

Login
University of Eastern Finland
OpenAccess
eRepo
erepo@uef.fi
OpenUEF
Service provided by
the University of Eastern Finland Library
Library web pages
Twitter
Facebook
Youtube
Library blog
 sitemap